Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale

Clinical Nutrition

Volumn 32, Issue 5, 2013, Pages 789-796

  Berghofer P ^a   Fragkos, K C ^b   Baxter, J P ^c   Forbes, A ^b   Joly, F ^d   Heinze, H ^a   Loth, S ^e   Pertkiewicz, M ^f   Messing, B ^d   Jeppesen, P B ^g  

^a Takeda Pharma GmbH   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c King's Cross Hospital   (United Kingdom)

^d HÔpital Beaujon ^*  (France)

^e Pierrel Research Europe GmbH   (Germany)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

^g Rigshospitalet   (Denmark)

Author keywords

Quality of life (QoL); Scale; Short bowel syndrome (SBS); Validation

Indexed keywords

PLACEBO; TEDUGLUTIDE;

ADULT; ARTICLE; CONSTRUCT VALIDITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOME PARENTERAL NUTRITION QUALITY OF LIFE QUESTIONNAIRE; HUMAN; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUESTIONNAIRE; RATING SCALE; REPRODUCIBILITY; RESPONSIVENESS INDEX; SEMI STRUCTURED INTERVIEW; SENSITIVITY ANALYSIS; SHORT BOWEL SYNDROME; SHORT BOWEL SYNDROME QUALITY OF LIFE SCALE; STATISTICAL PARAMETERS; TEST RETEST RELIABILITY; VALIDATION PROCESS; VALIDATION STUDY; VISUAL ANALOG SCALE;

CLASSICAL TEST THEORY; CTT; QUALITY OF LIFE (QOL); RESPONSIVENESS INDEX; RI; SCALE; SHORT BOWEL SYNDROME (SBS); VALIDATION; VAS; VISUAL ANALOGUE SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; COST OF ILLNESS; DIARRHEA; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RECEPTORS, GLUCAGON; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SHORT BOWEL SYNDROME;

EID: 84883294494     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.12.001     Document Type: Article

References (29)

1. Nightingale J., Woodward J.M. Guidelines for management of patients with a short bowel. Gut 2006, 55(Suppl. IV):iv1-iv12.
2. O'Keefe S.J.D., Buchman A.L., Fishbein T.M., Jeejeebhoy K.N., Jeppesen P.B., Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006, 4:6-10.
3. Edes T. Clinical management of short bowel syndrome. Enhancing the patient's quality of life. Postgrad Med 1990, 88:91-95.
4. Forbes A. Intestinal failure and short bowel syndrome. Medicine 2007, 3(4):231-235.
5. Goulet O., Joly F., Corriol O., Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transpl 2009, 14:256-261.
6. Lauverjat M., Hadj A.A., Vanhems P., Bouletreau P., Fouque D., Chambrier C. Chronic dehydration may impair renal function in patients with chronicintestinal failure on long-term parenteral nutrition. Clin Nutr 2006, 25:75-81.
7. Carlsson E., Berglund B., Nordgren S. Living with an ostomy and short bowel syndrome: practical aspects and impact on daily life. JWound Ostomy Cont Nurs 2001, 28(2):96-105.
8. European Commission implementing decision C 2012, 6147 of 30/08/2012:. http://ec.europa.eu/health/documents/community-register/html/h787.htm#ProcList.
9. Jeppesen P.B., Gilroy R., Pertkiewicz M., Allard J.P., Messing B., O'Keefe S.J. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011, 60(7):902-914.
10. Carlsson E., Bosaeus I., Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003, 22(5):445-452.
11. Kalaitzakis E., Carlsson E., Josefsson A., Bosaeus I. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms. Scand J Gastroenterol 2008, 43:1057-1065.
12. Richards D.M., Irving M.H. Assessing the quality of life of patients with intestinal failure on home parenteral nutrition. Gut 1997, 40:218-222.
13. Jeppesen P.B., Langholz E., Mortensen P.B. Quality of life in patients receiving home parenteral nutrition. Gut 1999, 44:844-852.
14. Jamieson C.P., Nortona B., Day T., Lakeman M., Powell-Tucka J. The quantitative effect of nutrition support on quality of life in outpatients. Clin Nutr 1997, 16(1):25-28.
15. Ladefoged K. Quality of life in patients on permanent home parenteral nutrition. JParenter Enteral Nutr 1981, 5:132-137.
16. Carlson G.L., Maguire G., Williams N., Bradley A., Shaffer J.L., Irving M.H. Quality of life on home parenteral nutrition: a single centre study of 37 patients. Clin Nutr 1995, 14:219-228.
17. Winkler M.F., Hagan E., Wetle T., Smith C., Maillet J.O., Touger-Decker R. An exploration of quality of life and the experience of living with home parenteral nutrition. JParenter Enteral Nutr 2010, 34(4):395-407.
18. Baxter J.P., Fayers P.M., McKinlay A.W. The development and translation of a treatment-specific quality of life questionnaire for adult patients on home parenteral nutrition. e-SPEN 2008, 3:e22-e28.
19. Staun M., Pironi L., Bozzetti F., Baxter J., Forbes A., Joly F., et al. ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009, 28:467-479.
20. Novick M.R. The axioms and principal results of classical test theory. JMath Psychol 1966, 3:1-18.
21. FDA Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims 2006, p. 4:79.
22. Jeppesen P.B., Pertkiewicz M., Messing B., Kishore I., Seidner D.L., O'Keefe S.J., et al. Teduglutide reduces need for parenteral support among patients with shortbowel syndrome with intestinal failure. Gastroenterology 2012, 143:1473-1481.
23. Bland J.M., Altman D.G. Cronbach's alpha. BMJ 1997, 314:572.
24. Cohen J. Statistical power analyses for the behavioral sciences 1988, Laurence Erlbaum Associates, Inc. Publishers, Hillsdale, New Jersey, USA. 2nd ed.
25. Guyatt G.H., Townsend M., Berman L.B., Keller J.L. Acomparison of Likert and visualanalogue scales for measuring change in function. JChron Dis 1987, 40:1129-1133.
26. Bailey K.D. Methods of social research 1987, Free Press, New York, p. 533. 3rd ed.
27. Scientific Advisory Committee Instrument review criteria. Med Outcomes Trust Bull 1995, 3:1-4.
28. McColl E., Junghard O., Wiklund I., Revicki D.A. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?. Am J Gastroenterol 2005, 100:11-18.
29. Holtmann G., Chassany O., DeVault K.R., Schmitt H., Gebauer U., Doerfler H., et al. International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2009, 29:615-625.